Skip to content

Author

M. Alharbi

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Computationally Driven Design and Structural Optimization of Thiazole-Benzamide Hybrids Incorporating ( R )- N -(1-(naphthalen-1-yl)ethyl)propenamide Scaffold as Potent SARS-CoV-2 Papain Like Protease (PL pro ): Synthesis, Biological Evaluation, Molecular Docking and DFT Studies

The papain-like protease (PL pro ) of severe respiratory syndrome coronavirus 2 (SARS-CoV-2) is a promising therapeutic target owing to its vital role in viral polyprotein processing and modulation of host immune responses. Therefore, in the present work, a library of thiazole-benzamide analogues 8a-l incorporating...

Rafaqat Hussain, H. Sarfraz, Uzma Azam et al. · 0 citations
Open access Nov 2026

Thiophen-2-ylsulfonyl indole-3-carbaldehyde thiosemicarbazones as selective prostate cancer agents: biological profiling and molecular targeting studies

A series of thiophen-2-ylsulfonyl indole-3-carbaldehyde thiosemicarbazone derivatives 5a–5t was synthesized and evaluated for anticancer activity using biological and computational methods. The cytotoxic activity of these compounds was tested on A549, LNCaP, and HUVEC cell lines utilizing the MTT assay, with sorafenib...

Kazma Batool, Hande İpek İnce, A. Şenol et al. · 0 citations
Open access Nov 2026

In silico drug repurposing to identify activators targeting SLC7A11/xCT for cardiotoxicity: Molecular docking, dynamics simulation, and ADMET analysis

Results suggest that dexamethasone and prulifloxacin are promising candidates for repurposing as cardioprotective agents, offering potential therapeutic options for mitigating drug-induced cardiotoxicity.

M. M. Alshehri, Nemat Ali, M. Alharbi et al. · 0 citations
Open access Oct 2026

Structure-based discovery of a novel Granzyme A (GZMA) inhibitor for autism spectrum disorder through integrative transcriptomics, virtual screening, and long-timescale molecular dynamics simulations

GZMA was transcriptionally downregulated in peripheral blood; its selection rests on network centrality and on the premise that granzyme pathology is governed by enzymatic activity at tissue sites rather than by circulating transcript abundance, a mechanistic hypothesis to be tested at the activity level.

M. Alharbi, Abdulrahman Alshammari, O. Al-shabanah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.